Freedman SB, Dawson GR, Iversen LL, Baker R, Hargreaves RJ (1993) <br />The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo<br /><i>Life Sciences</i> <b>52</b>: 489<br /><br />Iversen LL (1993) <br />Approaches to cholinergic therapy in Alzheimer's disease<br /><i>Prog Brain Res</i> <b>98</b>: 423<br /><br />Freedman SB, Patel S, Harley EA, Iversen LL, Baker R, Showell GA, Saunders J, McKnight A, Newberry N, Scholey K, Hargreaves R (1992) <br />L-687,306: a functionally selective and potent muscarinic M1 receptor agonist<br /><i>European Journal of Pharmacology</i> <b>215</b>: 135<br /><br />Saunders J, Cassidy M, Freedman SB, Harley EA, Iversen LL, Kneen C, MacLeod AM, Merchant KJ, Snow RJ, Baker R (1990) <br />Novel quinuclidine-based ligands for the muscarinic cholinergic receptor<br /><i>Journal of Medicinal Chemistry</i> <b>33</b>: 1128<br /><br />Freedman SB, Harley EA, Iversen LL (1988) <br />Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation<br /><i>Trends in Pharmacological Sciences</i> <b>Suppl</b>: 54<br /><br />Freedman SB, Harley EA, Iversen LL (1986) <br />Poster: Allosteric regulation of muscarinic receptors from rat brain<br /><i>Trends in Pharmacological Sciences</i> <b>Suppl</b>: 80<br /><br />Iversen LL (1986) <br />The cholinergic hypothesis of dementia<br /><i>Trends in Pharmacological Sciences</i> <b>Suppl</b>: 44<br /><br />Burnstock G, Hokfelt T, Gershon MD, Iversen LL, Kosterlitz HW, Szurszewski JH (1979) <br />Non-adrenergic, non-cholinergic autonomic neurotransmission mechanisms<br /><i>Neurosci Res Program Bull</i> <b>17</b>: 377<br /><br />Enna SJ, Bird ED, Bennett JP, Jr., Bylund DB, Yamamura HI, Iversen LL, Snyder SH (1976) <br />Huntington's chorea. Changes in neurotransmitter receptors in the brain<br /><i>N Engl J Med</i> <b>294</b>: 1305<br /><br />